CT-102 (Curative Technologies)

N/A

Report date: 2022/01/24 13:25:21

Base Information

Drug NameCT-102 (Curative Technologies)
Drug Alias NamePDWHFPlatelet-derived wound healing formulaCT-102 (Curative Technologies)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionIntercellular signaling peptides and proteins stimulants
TargetsIntercellular signaling peptides and proteins
Therapy Area/IndicationsSkin UlcerDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCurative Health Services
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCurative Health Services
Active IndicationsN/A
Inactive IndicationsSkin UlcerDiabetic Foot

Other Information

ATC CodeN/A
Related LinksN/A